09/2009 - Državni zavod za intelektualno vlasništvo

3504 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601
MKP Broj objave europske Naziv izuma
prijave patenta
(51) (97) (54)
A61K 31/165 (2006.01) EP 2094643 * N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS
FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES
A61K 31/165 (2006.01) EP 2099444 * USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS
A61K 31/167 (2006.01) EP 2099768 * AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE RECEPTOR
A61K 31/17 (2006.01) EP 2094643 * N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS
FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES
A61K 31/17 (2006.01) EP 2094653 * O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS TRPV1 RECEPTOR ANTAGONISTS
A61K 31/185 (2006.01) EP 2091529 * USE OF L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT IN THE FORM OF
EYE-DROPS FOR TREATING CORNEAL DISEASES
A61K 31/19 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR
ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT
A61K 31/192 (2006.01) EP 2089350 * CRYSTALLINE POTASSIUM SALT OF LIPOXIN A4 ANALOGS
A61K 31/192 (2006.01) EP 2099446 * METHOD OF TREATMENT FOR INFLAMMATORY BOWEL DISEASE
A61K 31/195 (2006.01) EP 2086530 * USE OF GABAPENTIN AND PREGABALIN PRODRUGS FOR TREATING TINNITUS
A61K 31/195 (2006.01) EP 2086924 * [F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED L-GLUTAMINE, DERIVATIVES
THEREOF AND USE THEREOF AND PROCESSES FOR THEIR PREPARATION
A61K 31/196 (2006.01) EP 2086504 * DICLOFENAC GEL
A61K 31/197 (2006.01) EP 2086530 * USE OF GABAPENTIN AND PREGABALIN PRODRUGS FOR TREATING TINNITUS
A61K 31/198 (2006.01) EP 2099447 * IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS
A61K 31/20 (2006.01) EP 2089014 * OMEGA-3 FATTY ACIDS AND DYSLIPIDEMIC AGENT FOR REDUCTION OF APO-B LEVELS
A61K 31/20 (2006.01) EP 2099295 * PROPHLYAXIS AND TREATMENT OF ATRIAL FIBRILLATION WITH OMEGA-3 FATTY
ACIDS
A61K 31/201 (2006.01) EP 2091528 * METHODS OF INACTIVATING VIRUSES
A61K 31/202 (2006.01) EP 2094640 * ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF
THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).
A61K 31/205 (2006.01) EP 2091529 * USE OF L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT IN THE FORM OF
EYE-DROPS FOR TREATING CORNEAL DISEASES
A61K 31/232 (2006.01) EP 2094640 * ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF
THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).
A61K 31/27 (2006.01) EP 2089015 * METHODS FOR TREATING DISRUPTIVE BEHAVIOR DISORDERS
A61K 31/325 (2006.01) EP 2089002 * PHENYLALKYL CARBAMATE COMPOSITIONS
A61K 31/33 (2006.01) EP 2094261 * PHARMACEUTICAL COMPOSITION CONTAINING NAPHTHOQUINONE-BASED
COMPOUND FOR INTESTINE DELIVERY SYSTEM
A61K 31/337 (2006.01) EP 2092941 Drug releasing coatings for medical devices
A61K 31/34 (2006.01) EP 2086509 * ESCITALOPRAM AND SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
A61K 31/34 (2006.01) EP 2099448 * PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF
RESTENOSIS
A61K 31/343 (2006.01) EP 2086509 * ESCITALOPRAM AND SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
A61K 31/343 (2006.01) EP 2094262 * PHARMACEUTICAL COMPOSITION CONTAINING PHENANTHRENEQUINONE-BASED
COMPOUND FOR INTESTINE DELIVERY SYSTEM
A61K 31/343 (2006.01) EP 2097399 * NOVEL INHIBITORS OF CHYMASE
A61K 31/352 (2006.01) EP 1886690 Pharmaceutical composition for the treatment of food intolerance
A61K 31/352 (2006.01) EP 2086533 * USE OF AN ADENOSINE ANTAGONIST
A61K 31/352 (2006.01) EP 2099449 * PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF
DISEASES INVOLVING IMPOTENCE
A61K 31/355 (2006.01) EP 2091529 * USE OF L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT IN THE FORM OF
EYE-DROPS FOR TREATING CORNEAL DISEASES
A61K 31/381 (2006.01) EP 2094272 * NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR
INHIBITORS
A61K 31/381 (2006.01) EP 2099791 * THIENYL-CONTAINING GLYCOPYRANOSYL DERIVATIVES AS ANTIDIABETICS
A61K 31/39 (2006.01) EP 2097420 * SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS
A61K 31/395 (2006.01) EP 2091919 * DERIVATIVES OF 18-AMINO SUBSTITUTED ANALOGS OF THE GELDAMYCIN
HYDROQUINON WITH CYTOTOXIC ACTIVITY FOR THE TREATMENT OF CANCER
A61K 31/395 (2006.01) EP 2097083 * DOSAGE FORMS AND CO-ADMINISTRATION OF AN OPIOID AGONIST AND AN OPIOID
ANTAGONIST
A61K 31/395 (2006.01) EP 2099795 * AZAADAMANTANE DERIVATIVES AND THEIR USES AS NICOTINIC ACETYLCHOLINE
RECEPTORS LIGANDS
A61K 31/397 (2006.01) EP 2091915 * NOVEL DIPHENYLAZETIDINONE SUBSTITUTED BY PIPERAZINE-1-SULFONIC ACID
HAVING IMPROVED PHARMACOLOGICAL PROPERTIES
A61K 31/397 (2006.01) EP 2099750 * NEW CRYSTALLINE FORMS
A61K 31/40 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS
A61K 31/40 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR
ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT
A61K 31/40 (2006.01) EP 2094656 * P